News and Events

Lifor Mentioned in Article "New Strategies to Optimize Kidney Recovery and Preservation in Transplantation"
Lifeblood Awarded US Army SBIR Oxygen Therapeutics Grant
Lifor Expands Organ Preservation Application Into Small Intestine
Lifeblood Receives India Patent
Lifeblood Licenses LiforCell Technology
Lifeblood Licenses LiforCell Technology
Freehold, NJ Oct 06, 2010 (Lifeblood Medical, Inc.)
 
Lifeblood Medical, Inc. has completed an exclusive worldwide licensing deal for the LiforCell® brand of products with Essential Pharmaceuticals, LLC. Essential Pharmaceutical will manage all of LiforCell®’s distribution, promotion, medical education, research and development, and all other aspects of LiforCell® as it relates to the serum, tissue freezing and transport, and pathology markets.
 
“I am excited with the partnership that we have created with Essential,” stated Joseph Fischer, President and Chief Executive Officer of Lifeblood Medical. “Essential is known for its outstanding customer support in highly specialized fields. That, along with the superior advantages of the LiforCell® family of products, will generate increased growth and market penetration of the Lifeblood technology.”
 
“This strategic partnership will allow Lifeblood to focus on its core business, which is room temperature organ preservation with its Lifor® technology. We will accelerate our research and development on other uses of Lifor®, which will include limb preservation and oxygen therapeutics.”
 
"Essential Pharmaceuticals is excited to use its proven research and communication capabilities to build on Lifeblood Medical's early success with LiforCell®" notes Allan Weber, CEO of Essential Pharmaceuticals. “The distinct advantages that LiforCell® brings to scientists, coupled with its broad scope of applications, will improve the effectiveness of their research on cell lines and tissues, and that of numerous other fields of medical research."
 
About Lifeblood Medical, Inc.
Lifeblood Medical, Inc., with headquarters in Adelphia, New Jersey, is dedicated to enhancing the gift of life through our innovative patented technology. The Company’s patented Lifor® products are focused on (1) extending organ preservation via room temperature, (2) limb preservation and (3) oxygen therapeutics. Lifeblood’s commitment to innovation continues with expansion of the applications of Lifor® through research and development.
 
General Inquiries        
Joseph Fischer
President and CEO, Lifeblood Medical, Inc.
732-431-5833
 


HomeAbout UsLiforStudiesGrant Writing OpportunitiesOrgan PreservationOxygen TherapeuticsPurchase LiforLifor MSDSNews and EventsFrost & Sullivan Award WinnerFavorite LinksSite Map